Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0PYXOB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-CD30 antibody drug conjugate (NBE-Therapeutics)
|
|||||
| Synonyms |
Anti-CD30 antibody drug conjugate
Click to Show/Hide
|
|||||
| Organization |
NBE-Therapeutics AG
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Cutaneous mesenchymal large cell lymphoma [ICD11:2B00]
Clinical candidate
Hodgkin lymphoma [ICD11:2B30]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor necrosis factor receptor superfamily member 8 (TNFRSF8)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.